Direct in vivo testing indicated that CD8+ T-cells pre-cultured for 7 days on substrate-immobilized CCL21 + ICAM1 suppressed tumor growth to a significantly greater extent than T-cells cultured on unmodified substrates (Figure 7). The gene discussed is ICAM1; the disease is neoplasm.